drugset / Trial / NCT00670033
Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to describe the safety and IOP-lowering efficacy of Travoprost New Formulations compared to TRAVATAN® and to vehicle in patients with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2008-04
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Travoprost | Other / unclassified | 0.004 % | Other |
| Comparator | Travoprost | Other / unclassified | — | Other |